San Francisco Sentry Investment Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$73K Buy
1,380
+190
+16% +$9.91K 0.04% 319
2021
Q1
$59K Hold
1,190
0.03% 359
2020
Q4
$58K Hold
1,190
0.03% 335
2020
Q3
$60K Sell
1,190
-525
-31% -$27K 0.03% 313
2020
Q2
$88K Hold
1,715
0.05% 273
2020
Q1
$75K Sell
1,715
-5
-0.3% -$239 0.05% 247
2019
Q4
$86K Hold
1,720
0.04% 310
2019
Q3
$80K Hold
1,720
0.04% 312
2019
Q2
$74K Hold
1,720
0.03% 326
2019
Q1
$76K Buy
+1,720
New +$73.7K 0.03% 349
2018
Q1
Sell
-644
Closed -$28K 937
2017
Q4
$28K Buy
+644
New +$29.7K 0.01% 516
2014
Q2
Sell
-430
Closed -$22K 657
2014
Q1
$22K Sell
430
-266
-38% -$13.5K 0.01% 441
2013
Q4
$37K Sell
696
-102
-13% -$5.26K 0.01% 365
2013
Q3
$40K Hold
798
0.02% 332
2013
Q2
$41K Buy
+798
New +$42.5K 0.01% 329

Other funds holding SNY

San Francisco Sentry Investment Group's SNY Position: Q2 2021 in Review

San Francisco Sentry Investment Group increased its Sanofi (SNY) stake by 16% in Q2 2021, buying an estimated $9.91K and bringing the position to 1,380 shares worth $73K. The position accounts for 0.04% of the portfolio, ranked #319.

San Francisco Sentry Investment Group first reported a position in SNY in Q2 2013 and has held it in 15 quarters since. The position peaked at $88K in Q2 2020. 586 funds tracked by Wall St. Rank hold SNY as of Q2 2021.

  • San Francisco Sentry Investment Group held 1,380 shares of Sanofi worth $73K as of Q2 2021.
  • San Francisco Sentry Investment Group bought 190 Sanofi shares in Q2 2021, an estimated $9.91K.
  • Sanofi made up 0.04% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #319 holding.
  • San Francisco Sentry Investment Group first reported a position in Sanofi in Q2 2013 and has held it in 15 quarters since.
  • San Francisco Sentry Investment Group's Sanofi position peaked at $88K in Q2 2020.
  • 586 funds tracked by Wall St. Rank held Sanofi as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.